332 related articles for article (PubMed ID: 22011624)
1. Regulation of glucose metabolism via hepatic forkhead transcription factor 1 (FoxO1) by Morinda citrifolia (noni) in high-fat diet-induced obese mice.
Nerurkar PV; Nishioka A; Eck PO; Johns LM; Volper E; Nerurkar VR
Br J Nutr; 2012 Jul; 108(2):218-228. PubMed ID: 22011624
[TBL] [Abstract][Full Text] [Related]
2. Fermented noni (
Zhang X; Zhang B; Li L; Li X; Zhang J; Chen G
Food Funct; 2022 Aug; 13(15):8254-8273. PubMed ID: 35833945
[TBL] [Abstract][Full Text] [Related]
3. Spexin alleviates insulin resistance and inhibits hepatic gluconeogenesis via the FoxO1/PGC-1α pathway in high-fat-diet-induced rats and insulin resistant cells.
Gu L; Ding X; Wang Y; Gu M; Zhang J; Yan S; Li N; Song Z; Yin J; Lu L; Peng Y
Int J Biol Sci; 2019; 15(13):2815-2829. PubMed ID: 31853220
[No Abstract] [Full Text] [Related]
4. Lipocalin-2: a role in hepatic gluconeogenesis via AMP-activated protein kinase (AMPK).
Sun WX; Lou K; Chen LJ; Liu SD; Pang SG
J Endocrinol Invest; 2021 Aug; 44(8):1753-1765. PubMed ID: 33423221
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid receptor type 1 mediates high-fat diet-induced insulin resistance by increasing forkhead box O1 activity in a mouse model of obesity.
Chen CC; Lee TY; Kwok CF; Hsu YP; Shih KC; Lin YJ; Ho LT
Int J Mol Med; 2016 Mar; 37(3):743-54. PubMed ID: 26847930
[TBL] [Abstract][Full Text] [Related]
6. Acute exercise reduces hepatic glucose production through inhibition of the Foxo1/HNF-4alpha pathway in insulin resistant mice.
De Souza CT; Frederico MJ; da Luz G; Cintra DE; Ropelle ER; Pauli JR; Velloso LA
J Physiol; 2010 Jun; 588(Pt 12):2239-53. PubMed ID: 20421289
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin F
Wang Y; Yan S; Xiao B; Zuo S; Zhang Q; Chen G; Yu Y; Chen D; Liu Q; Liu Y; Shen Y; Yu Y
Diabetes; 2018 Sep; 67(9):1748-1760. PubMed ID: 29773555
[TBL] [Abstract][Full Text] [Related]
8. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
[TBL] [Abstract][Full Text] [Related]
9. GdCl3 reduces hyperglycaemia through Akt/FoxO1-induced suppression of hepatic gluconeogenesis in Type 2 diabetic mice.
Wang Q; Wang N; Dong M; Chen F; Li Z; Chen Y
Clin Sci (Lond); 2014 Jul; 127(2):91-100. PubMed ID: 24444370
[TBL] [Abstract][Full Text] [Related]
10. Sodium meta-arsenite ameliorates hyperglycemia in obese diabetic db/db mice by inhibition of hepatic gluconeogenesis.
Lee YS; Lee EK; Oh HH; Choi CS; Kim S; Jun HS
J Diabetes Res; 2014; 2014():961732. PubMed ID: 25610880
[TBL] [Abstract][Full Text] [Related]
11. Ginsenoside Rg1 Inhibits Glucagon-Induced Hepatic Gluconeogenesis through Akt-FoxO1 Interaction.
Liu Q; Zhang FG; Zhang WS; Pan A; Yang YL; Liu JF; Li P; Liu BL; Qi LW
Theranostics; 2017; 7(16):4001-4012. PubMed ID: 29109794
[No Abstract] [Full Text] [Related]
12. The role of class I histone deacetylase (HDAC) on gluconeogenesis in liver.
Oiso H; Furukawa N; Suefuji M; Shimoda S; Ito A; Furumai R; Nakagawa J; Yoshida M; Nishino N; Araki E
Biochem Biophys Res Commun; 2011 Jan; 404(1):166-72. PubMed ID: 21108932
[TBL] [Abstract][Full Text] [Related]
13. Exercise training decreases mitogen-activated protein kinase phosphatase-3 expression and suppresses hepatic gluconeogenesis in obese mice.
Souza Pauli LS; Ropelle EC; de Souza CT; Cintra DE; da Silva AS; de Almeida Rodrigues B; de Moura LP; Marinho R; de Oliveira V; Katashima CK; Pauli JR; Ropelle ER
J Physiol; 2014 Mar; 592(6):1325-40. PubMed ID: 24396063
[TBL] [Abstract][Full Text] [Related]
14. Bradykinin inhibits hepatic gluconeogenesis in obese mice.
Barros CC; Haro A; Russo FJ; Schadock I; Almeida SS; Reis FC; Moraes MR; Haidar A; Hirata AE; Mori M; Bacurau RF; Würtele M; Bader M; Pesquero JB; Araujo RC
Lab Invest; 2012 Oct; 92(10):1419-27. PubMed ID: 22868909
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA H19 inhibition promotes hyperglycemia in mice by upregulating hepatic FoxO1 levels and promoting gluconeogenesis.
Goyal N; Tiwary S; Kesharwani D; Datta M
J Mol Med (Berl); 2019 Jan; 97(1):115-126. PubMed ID: 30465059
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of lncRNA MEG3 promotes hepatic insulin resistance via increasing FoxO1 expression.
Zhu X; Wu YB; Zhou J; Kang DM
Biochem Biophys Res Commun; 2016 Jan; 469(2):319-25. PubMed ID: 26603935
[TBL] [Abstract][Full Text] [Related]
17. MAPK phosphatase-3 promotes hepatic gluconeogenesis through dephosphorylation of forkhead box O1 in mice.
Wu Z; Jiao P; Huang X; Feng B; Feng Y; Yang S; Hwang P; Du J; Nie Y; Xiao G; Xu H
J Clin Invest; 2010 Nov; 120(11):3901-11. PubMed ID: 20921625
[TBL] [Abstract][Full Text] [Related]
18. Elovl5 regulates the mTORC2-Akt-FOXO1 pathway by controlling hepatic cis-vaccenic acid synthesis in diet-induced obese mice.
Tripathy S; Jump DB
J Lipid Res; 2013 Jan; 54(1):71-84. PubMed ID: 23099444
[TBL] [Abstract][Full Text] [Related]
19. Cyanidin 3-glucoside attenuates obesity-associated insulin resistance and hepatic steatosis in high-fat diet-fed and db/db mice via the transcription factor FoxO1.
Guo H; Xia M; Zou T; Ling W; Zhong R; Zhang W
J Nutr Biochem; 2012 Apr; 23(4):349-60. PubMed ID: 21543211
[TBL] [Abstract][Full Text] [Related]
20. Hepatic NPC1L1 overexpression ameliorates glucose metabolism in diabetic mice via suppression of gluconeogenesis.
Kurano M; Hara M; Satoh H; Tsukamoto K
Metabolism; 2015 May; 64(5):588-96. PubMed ID: 25660144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]